MicroRNAs in Medicine 2013
DOI: 10.1002/9781118300312.ch40
|View full text |Cite
|
Sign up to set email alerts
|

Locked Nucleic Acids as MicroRNA Therapeutics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 40 publications
0
4
0
Order By: Relevance
“…37 One of the Anti-miRs is LNA that was used to inhibit oncomiRs. 23 In this study, it was determined that degradation of miR-21 with LNA-anti-miR could prevent proliferation of HepG2 cells and seemed that miR-21 is an oncomiR in HCC. In treatment of cancer, the destruction of cells with uncontrolled proliferation seems to be an aim.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…37 One of the Anti-miRs is LNA that was used to inhibit oncomiRs. 23 In this study, it was determined that degradation of miR-21 with LNA-anti-miR could prevent proliferation of HepG2 cells and seemed that miR-21 is an oncomiR in HCC. In treatment of cancer, the destruction of cells with uncontrolled proliferation seems to be an aim.…”
Section: Discussionmentioning
confidence: 99%
“…4,20-22 Locked nucleic acid (LNA) is a new lineage of modified oligonucleotide that has a 2'-O 4'-C Methylene bridge in its structure leading to consistently high temperature and resistance to enzymatic degradation. [23][24][25] The effect and safety of LNA-anti-miRs for degradation of miRNAs have been shown in several studies, suggesting them as suitable candidates for therapeutic applications. 23,26 In this study, we have used LNA-anti-miR for degradation of miR-21 in HCC.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In an miRNA-based therapeutic strategy, the miRNA expression, which is altered in different diseases, is corrected by injecting the downregulated miRNAs or by inhibiting the upregulated ones. Antisense miRNAs that have been chemically transformed to have improved durability are used in locked nucleic acid (LNA) or antagomirs administered in nanoparticle form as present therapeutics to downregulate miRNA expression [ 132 , 133 ]. miRNA mimics are similarly used to restore miRNA function.…”
Section: Therapeutic Considerationsmentioning
confidence: 99%